Manhattan Scientifics Announces Breakthrough Device for Detection of Cancer

NEW YORK–(BUSINESS WIRE)–Manhattan Scientifics Inc.’s (OTC: QB MHTX) former wholly-owned subsidiary that was initially funded by MHTX, Imagion Biosystems Ltd (ASX:IBX) over a nine-year period has received confirmation from the Food and Drug Administration (FDA) that the MagSense System and Test for staging HER2 breast cancer has qualified for and been granted designation as a … [Read more…]

LC GC® Presents Webcast on Automated Volatiles Analysis

The live broadcast will feature insight from key industry leaders CRANBURY, N.J.–(BUSINESS WIRE)–#Chromatography—LC GC®, a leading multimedia platform of peer-reviewed technical information on the field of chromatography and the separation sciences, will host the webcast “High-Throughput, Automated Volatiles Analysis From Air, Headspace and Thermal Desorption Tubes” on Tuesday, July 23, at 11 a.m. EDT. “Conventional … [Read more…]

PER® Global Presents the 4th Annual European Congress on Immunotherapies in Cancer™ in Barcelona

Continuing medical education conference will focus on the latest emerging data on immunotherapies CRANBURY, N.J.–(BUSINESS WIRE)–PER Global, a worldwide leading resource for continuing medical education, will host the 4th Annual European Congress on Immunotherapies in Cancer™. The congress will take place 15-16 Nov. 2019 at the Hilton Barcelona in Spain. This year’s program will be … [Read more…]

Sam’s Club® Is Partnering with Lucid Hearing® and Liberty Hearing Aids® to Provide the Latest Hearing Technology with Prices that Undercut National Competitors

FORT WORTH, Texas–(BUSINESS WIRE)–#LucidHearing–Lucid Hearing is pleased to announce that Sam’s Club has the latest hearing technology that incorporates Bluetooth® communication to the iPhone® with Lucid® digital technology and is value priced at $1399.98 a pair. The U24 channel hearing aids include Lucid Clear™ advanced noise reduction and low-level and impulse noise suppression. Lucid Hearing … [Read more…]

Peak Health Announces the Release of “Diabet” – a 100% Natural, Plant-Based Supplement That Shows Breakthrough Potential for Supporting Healthy Blood Sugar Levels

Pilot studies suggest that a single course for 45 days can significantly reduce fasting glucose levels LOS GATOS, Calif.–(BUSINESS WIRE)–#EndoPhytoSystem–Peak Health Center, a 501(c)(3), not-for-profit California corporation, announces the release of Diabet – a 100% natural, plant-based supplement that shows breakthrough potential for supporting healthy blood sugar levels. Diabet is a liquid extract of spiral … [Read more…]

Lysogene Establishes Scientific Advisory Board with International Experts in CNS Gene Therapy

PARIS–(BUSINESS WIRE)–Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, Phase 3, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of world-leading experts in gene therapy discovery and development. “Gene therapy using recombinant adeno-associated virus (AAV) vectors is changing … [Read more…]

Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases

TG6002 has multiple mechanisms of action for enhanced anti-tumor activity: oncolysis, local production of chemotherapy in tumor and cell-mediated immune response The Phase 1/2a trial is expected to start in Q4 2019 STRASBOURG, France–(BUSINESS WIRE)–$TNG #OncolyticVirus–Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today … [Read more…]

Worldwide Genetic Testing Market Outlook 2019-2027 – Increasing Number of Patients Seeking Genetic Counseling & Testing Presents Lucrative Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Genetic Testing Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The global genetic testing market to proliferate with a compound annual growth rate of 11.53% in the forecast years 2019-2027. The high growth rate for the genetic testing market can mainly be credited to the increasing emphasis on early disease diagnosis … [Read more…]

Study Shows Spatial Biology Is Essential for Predicting Response to Immuno-Oncology Treatment

In JAMA Oncology report, multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies MENLO PARK, Calif.–(BUSINESS WIRE)–Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types conducted by scientists at Johns Hopkins University, Yale University, and other institutions determined that multiplex immunofluorescence with spatial characterization significantly … [Read more…]

Global Aesthetic Laser Market Set to Record a CAGR of 11.24% During 2019-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Aesthetic Laser Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The global aesthetic laser market is progressing in terms of revenue, with an anticipated CAGR of 11.24% during the estimated period of 2019-2027. The advancements in laser technology, rising demand for minimally invasive procedures in dermatology and rising elderly population are … [Read more…]